American Century Companies
KYMR icon

American Century Companies’s Kymera Therapeutics KYMR Stock Holding History

American Century Companies’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,819
Closed -$219K – 2888
2025
Q4 		$219K Buy
+2,819
New +$190K ﹤0.01% 2692
2024
Q4 		– Sell
-9,298
Closed -$440K – 2924
2024
Q3 		$440K Sell
9,298
-1,549
-14% -$68.4K ﹤0.01% 2517
2024
Q2 		$324K Sell
10,847
-36,820
-77% -$1.27M ﹤0.01% 2593
2024
Q1 		$1.92M Buy
47,667
+24,893
+109% +$891K ﹤0.01% 1902
2023
Q4 		$580K Sell
22,774
-211,784
-90% -$3.79M ﹤0.01% 2312
2023
Q3 		$3.26M Buy
234,558
+124,005
+112% +$2.49M ﹤0.01% 1499
2023
Q2 		$2.54M Sell
110,553
-4,489
-4% -$129K ﹤0.01% 1566
2023
Q1 		$3.4M Buy
115,042
+4,328
+4% +$140K ﹤0.01% 1404
2022
Q4 		$2.76M Sell
110,714
-117,496
-51% -$3.13M ﹤0.01% 1456
2022
Q3 		$4.97M Buy
228,210
+1,351
+0.6% +$35.6K ﹤0.01% 1108
2022
Q2 		$4.47M Buy
226,859
+13,899
+7% +$325K ﹤0.01% 1146
2022
Q1 		$9.01M Buy
212,960
+25,933
+14% +$1.1M 0.01% 944
2021
Q4 		$11.9M Buy
187,027
+36,281
+24% +$2.11M 0.01% 835
2021
Q3 		$8.86M Buy
150,746
+52
+0% +$3.02K 0.01% 878
2021
Q2 		$7.31M Buy
150,694
+362
+0.2% +$15.7K 0.01% 896
2021
Q1 		$5.84M Sell
150,332
-1,243
-0.8% -$74.8K ﹤0.01% 898
2020
Q4 		$9.4M Sell
151,575
-198
-0.1% -$9.66K 0.01% 776
2020
Q3 		$4.9M Buy
+151,773
New +$4.63M ﹤0.01% 806

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

American Century Companies's KYMR Position: Q1 2026 in Review

American Century Companies sold out of Kymera Therapeutics (KYMR) in Q1 2026, closing a stake of 2,819 shares — an estimated $219K sold.

American Century Companies first reported a position in KYMR in Q3 2020 and held it in 18 quarters. The position peaked at $11.9M in Q4 2021. 256 funds tracked by Wall St. Rank hold KYMR as of Q1 2026.

  • American Century Companies reported no remaining Kymera Therapeutics position as of Q1 2026 after selling out during the quarter.
  • American Century Companies sold 2,819 Kymera Therapeutics shares in Q1 2026, an estimated $219K.
  • American Century Companies first reported a position in Kymera Therapeutics in Q3 2020 and held it in 18 quarters.
  • American Century Companies's Kymera Therapeutics position peaked at $11.9M in Q4 2021.
  • 256 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.